id int64 | testing_level string | lab_id string | country_income string | region_type string | has_HPLC int64 | has_dissolution_apparatus int64 | has_mass_spec int64 | WHO_prequalified_lab int64 | staff_analysts int64 | medicine_name string | therapeutic_category string | dosage_form string | storage_requirement string | reference_price_usd float64 | collection_point string | registered_product int64 | manufacturer_country string | WHO_prequalified_product int64 | year int64 | quarter int64 | primary_test_method string | quality_test_result string | sf_classification string | failure_type string | API_content_pct_label float64 | dissolution_pass int64 | turnaround_days int64 | confirmatory_test_done int64 | regulatory_action_taken int64 | product_recalled int64 | manufacturer_notified int64 | WHO_alert_issued int64 | estimated_patient_exposure int64 | report_to_WHO_GSM int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
101 | regional_lab | QCL_0074 | lower_middle_income | peri_urban | 1 | 0 | 0 | 0 | 5 | amoxicillin_500mg | antibiotic | capsule | ambient | 0.02 | wholesale_distributor | 1 | unknown | 0 | 2,021 | 4 | UV_spectrophotometry | pass | compliant | not_applicable | 99.3 | 1 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
102 | regional_lab | QCL_0043 | low_income | rural | 1 | 0 | 0 | 0 | 4 | ciprofloxacin_500mg | antibiotic | tablet | ambient | 0.04 | private_pharmacy | 0 | China | 0 | 2,024 | 1 | UV_spectrophotometry | pass | compliant | not_applicable | 98.1 | 1 | 31 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
103 | regional_lab | QCL_0055 | low_income | urban | 1 | 0 | 0 | 0 | 3 | cotrimoxazole_480mg | antibiotic | tablet | ambient | 0.01 | private_pharmacy | 1 | China | 0 | 2,022 | 2 | HPLC | pass | compliant | not_applicable | 95 | 1 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
104 | regional_lab | QCL_0033 | low_income | peri_urban | 1 | 0 | 0 | 0 | 5 | doxycycline_100mg | antibiotic | capsule | ambient | 0.03 | private_clinic | 0 | China | 0 | 2,021 | 1 | thin_layer_chromatography | pass | compliant | not_applicable | 99.7 | 1 | 23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
105 | regional_lab | QCL_0072 | lower_middle_income | peri_urban | 1 | 0 | 0 | 0 | 5 | metronidazole_400mg | antibiotic | tablet | ambient | 0.02 | private_pharmacy | 0 | India | 0 | 2,023 | 2 | thin_layer_chromatography | fail | substandard | moisture_content | 97.3 | 1 | 4 | 1 | 0 | 0 | 0 | 0 | 7 | 0 |
106 | regional_lab | QCL_0004 | low_income | rural | 1 | 0 | 0 | 0 | 7 | artemether_lumefantrine | antimalarial | tablet | ambient | 0.04 | private_pharmacy | 1 | unknown | 0 | 2,021 | 1 | HPLC | fail | substandard | insufficient_API | 64.2 | 0 | 11 | 1 | 0 | 0 | 0 | 0 | 9 | 0 |
107 | regional_lab | QCL_0024 | lower_middle_income | peri_urban | 1 | 0 | 0 | 0 | 5 | artesunate_injection | antimalarial | injection | ambient | 0.8 | private_pharmacy | 1 | India | 0 | 2,021 | 3 | thin_layer_chromatography | pass | compliant | not_applicable | 93.6 | 1 | 30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
108 | regional_lab | QCL_0055 | low_income | urban | 1 | 0 | 0 | 0 | 4 | SP_sulfadoxine_pyrimethamine | antimalarial | tablet | ambient | 0.03 | central_medical_store | 1 | India | 1 | 2,021 | 4 | HPLC | pass | compliant | not_applicable | 97.3 | 1 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
109 | regional_lab | QCL_0034 | low_income | peri_urban | 1 | 0 | 0 | 0 | 1 | chloroquine_250mg | antimalarial | tablet | ambient | 0.01 | public_health_centre | 0 | unknown | 0 | 2,024 | 2 | UV_spectrophotometry | pass | compliant | not_applicable | 97.1 | 1 | 43 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
110 | regional_lab | QCL_0058 | upper_middle_income | peri_urban | 1 | 0 | 0 | 0 | 7 | paracetamol_500mg | analgesic | tablet | ambient | 0.005 | informal_market | 1 | Europe | 0 | 2,023 | 4 | GPHF_Minilab | fail | substandard | dissolution_failure | 96 | 0 | 3 | 1 | 0 | 0 | 0 | 0 | 11 | 0 |
111 | regional_lab | QCL_0015 | upper_middle_income | peri_urban | 1 | 0 | 0 | 0 | 5 | ibuprofen_400mg | analgesic | tablet | ambient | 0.01 | private_pharmacy | 1 | China | 0 | 2,024 | 2 | HPLC | pass | compliant | not_applicable | 97.9 | 1 | 59 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
112 | regional_lab | QCL_0014 | lower_middle_income | urban | 1 | 0 | 0 | 0 | 6 | metformin_500mg | antidiabetic | tablet | ambient | 0.01 | public_hospital_pharmacy | 1 | USA | 1 | 2,023 | 1 | HPLC | pass | compliant | not_applicable | 96.5 | 1 | 29 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
113 | regional_lab | QCL_0021 | low_income | peri_urban | 1 | 0 | 0 | 0 | 3 | amlodipine_5mg | antihypertensive | tablet | ambient | 0.01 | central_medical_store | 1 | unknown | 0 | 2,023 | 1 | GPHF_Minilab | fail | falsified | wrong_labelling | 86.1 | 1 | 22 | 1 | 0 | 0 | 0 | 0 | 245 | 0 |
114 | regional_lab | QCL_0068 | lower_middle_income | urban | 1 | 0 | 0 | 0 | 3 | omeprazole_20mg | GI | capsule | ambient | 0.03 | public_hospital_pharmacy | 0 | local_SSA | 0 | 2,024 | 2 | HPLC | pass | compliant | not_applicable | 105 | 1 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
115 | regional_lab | QCL_0067 | low_income | urban | 1 | 0 | 0 | 0 | 4 | ORS_sachet | essential | powder | ambient | 0.05 | private_pharmacy | 1 | Europe | 0 | 2,023 | 1 | GPHF_Minilab | pass | compliant | not_applicable | 97.6 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
116 | regional_lab | QCL_0057 | lower_middle_income | rural | 1 | 0 | 0 | 0 | 3 | oxytocin_10IU | maternal | injection | cold_chain | 0.15 | online_purchase | 0 | local_SSA | 0 | 2,024 | 2 | UV_spectrophotometry | fail | substandard | impurity_above_limit | 83.2 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 9 | 0 |
117 | regional_lab | QCL_0071 | lower_middle_income | urban | 1 | 0 | 0 | 0 | 4 | insulin_regular | antidiabetic | injection | cold_chain | 5 | central_medical_store | 1 | local_SSA | 0 | 2,022 | 2 | HPLC | fail | substandard | insufficient_API | 20.3 | 0 | 39 | 0 | 0 | 0 | 0 | 0 | 405 | 0 |
118 | regional_lab | QCL_0069 | low_income | peri_urban | 1 | 0 | 0 | 0 | 6 | TLD_dolutegravir | ARV | tablet | ambient | 0.12 | private_pharmacy | 1 | India | 0 | 2,023 | 2 | GPHF_Minilab | fail | falsified | wrong_API | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 25 | 0 |
119 | regional_lab | QCL_0034 | lower_middle_income | peri_urban | 1 | 0 | 0 | 0 | 6 | nevirapine_suspension | ARV | liquid | ambient | 0.08 | public_hospital_pharmacy | 1 | India | 0 | 2,022 | 2 | thin_layer_chromatography | fail | substandard | impurity_above_limit | 87.9 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 22 | 0 |
120 | regional_lab | QCL_0061 | lower_middle_income | peri_urban | 1 | 0 | 0 | 0 | 4 | diethylcarbamazine_50mg | anthelmintic | tablet | ambient | 0.02 | private_pharmacy | 0 | local_SSA | 0 | 2,023 | 2 | HPLC | pass | compliant | not_applicable | 105.7 | 1 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
121 | regional_lab | QCL_0034 | low_income | urban | 1 | 0 | 0 | 0 | 4 | amoxicillin_500mg | antibiotic | capsule | ambient | 0.02 | street_vendor | 0 | India | 0 | 2,021 | 2 | HPLC | fail | substandard | moisture_content | 98.7 | 1 | 3 | 1 | 0 | 0 | 0 | 0 | 19 | 0 |
122 | regional_lab | QCL_0045 | lower_middle_income | rural | 1 | 0 | 0 | 0 | 2 | ciprofloxacin_500mg | antibiotic | tablet | ambient | 0.04 | private_clinic | 0 | Europe | 0 | 2,024 | 1 | GPHF_Minilab | pass | compliant | not_applicable | 92.4 | 1 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
123 | regional_lab | QCL_0069 | upper_middle_income | rural | 1 | 0 | 0 | 0 | 5 | cotrimoxazole_480mg | antibiotic | tablet | ambient | 0.01 | private_clinic | 1 | unknown | 0 | 2,021 | 2 | HPLC | pass | compliant | not_applicable | 103.8 | 1 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
124 | regional_lab | QCL_0009 | lower_middle_income | peri_urban | 1 | 0 | 0 | 0 | 12 | doxycycline_100mg | antibiotic | capsule | ambient | 0.03 | public_health_centre | 0 | China | 0 | 2,023 | 1 | HPLC | fail | substandard | disintegration_failure | 88.4 | 1 | 13 | 1 | 0 | 0 | 0 | 0 | 52 | 0 |
125 | regional_lab | QCL_0002 | low_income | urban | 1 | 0 | 0 | 0 | 5 | metronidazole_400mg | antibiotic | tablet | ambient | 0.02 | online_purchase | 0 | China | 0 | 2,023 | 3 | HPLC | fail | substandard | uniformity_failure | 89.8 | 1 | 20 | 1 | 1 | 1 | 1 | 0 | 41 | 0 |
126 | regional_lab | QCL_0078 | low_income | peri_urban | 1 | 0 | 0 | 0 | 7 | artemether_lumefantrine | antimalarial | tablet | ambient | 0.04 | public_hospital_pharmacy | 0 | unknown | 0 | 2,023 | 1 | UV_spectrophotometry | fail | substandard | dissolution_failure | 89 | 0 | 47 | 0 | 0 | 0 | 0 | 0 | 44 | 1 |
127 | regional_lab | QCL_0048 | upper_middle_income | peri_urban | 1 | 0 | 0 | 0 | 4 | artesunate_injection | antimalarial | injection | ambient | 0.8 | public_health_centre | 0 | India | 0 | 2,021 | 4 | UV_spectrophotometry | fail | falsified | counterfeit_packaging | 97.3 | 1 | 13 | 0 | 1 | 0 | 0 | 0 | 34 | 0 |
128 | regional_lab | QCL_0049 | lower_middle_income | urban | 1 | 0 | 0 | 0 | 4 | SP_sulfadoxine_pyrimethamine | antimalarial | tablet | ambient | 0.03 | private_clinic | 0 | China | 0 | 2,022 | 3 | HPLC | pass | compliant | not_applicable | 99 | 1 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
129 | regional_lab | QCL_0049 | low_income | peri_urban | 1 | 0 | 0 | 0 | 5 | chloroquine_250mg | antimalarial | tablet | ambient | 0.01 | public_health_centre | 0 | India | 0 | 2,023 | 2 | thin_layer_chromatography | pass | compliant | not_applicable | 100.1 | 1 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
130 | regional_lab | QCL_0038 | low_income | rural | 1 | 0 | 0 | 0 | 3 | paracetamol_500mg | analgesic | tablet | ambient | 0.005 | wholesale_distributor | 1 | local_SSA | 0 | 2,023 | 1 | GPHF_Minilab | fail | substandard | insufficient_API | 74.4 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 66 | 0 |
131 | regional_lab | QCL_0007 | lower_middle_income | rural | 1 | 0 | 0 | 0 | 4 | ibuprofen_400mg | analgesic | tablet | ambient | 0.01 | private_pharmacy | 0 | unknown | 0 | 2,022 | 2 | thin_layer_chromatography | pass | compliant | not_applicable | 98.9 | 1 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
132 | regional_lab | QCL_0037 | low_income | rural | 1 | 0 | 0 | 0 | 7 | metformin_500mg | antidiabetic | tablet | ambient | 0.01 | wholesale_distributor | 0 | unknown | 0 | 2,024 | 3 | GPHF_Minilab | fail | substandard | dissolution_failure | 93.6 | 0 | 17 | 1 | 0 | 0 | 0 | 0 | 65 | 1 |
133 | regional_lab | QCL_0047 | upper_middle_income | peri_urban | 1 | 0 | 0 | 0 | 5 | amlodipine_5mg | antihypertensive | tablet | ambient | 0.01 | street_vendor | 0 | China | 0 | 2,024 | 2 | HPLC | pass | compliant | not_applicable | 103.2 | 1 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
134 | regional_lab | QCL_0014 | upper_middle_income | peri_urban | 1 | 0 | 0 | 0 | 6 | omeprazole_20mg | GI | capsule | ambient | 0.03 | public_health_centre | 0 | India | 0 | 2,022 | 4 | HPLC | pass | compliant | not_applicable | 96 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
135 | regional_lab | QCL_0059 | lower_middle_income | peri_urban | 1 | 0 | 0 | 0 | 8 | ORS_sachet | essential | powder | ambient | 0.05 | wholesale_distributor | 0 | India | 0 | 2,023 | 3 | HPLC | pass | compliant | not_applicable | 103.4 | 1 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
136 | regional_lab | QCL_0039 | upper_middle_income | peri_urban | 1 | 0 | 0 | 0 | 5 | oxytocin_10IU | maternal | injection | cold_chain | 0.15 | private_pharmacy | 0 | local_SSA | 0 | 2,023 | 3 | HPLC | pass | compliant | not_applicable | 96.1 | 1 | 35 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
137 | regional_lab | QCL_0025 | low_income | peri_urban | 1 | 0 | 0 | 0 | 5 | insulin_regular | antidiabetic | injection | cold_chain | 5 | private_clinic | 0 | India | 0 | 2,023 | 1 | UV_spectrophotometry | pass | compliant | not_applicable | 96 | 1 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
138 | regional_lab | QCL_0021 | lower_middle_income | urban | 1 | 0 | 0 | 0 | 2 | TLD_dolutegravir | ARV | tablet | ambient | 0.12 | public_health_centre | 0 | India | 0 | 2,022 | 3 | UV_spectrophotometry | fail | substandard | uniformity_failure | 96.1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 25 | 0 |
139 | regional_lab | QCL_0062 | lower_middle_income | urban | 1 | 0 | 0 | 0 | 7 | nevirapine_suspension | ARV | liquid | ambient | 0.08 | informal_market | 0 | local_SSA | 0 | 2,024 | 1 | HPLC | fail | falsified | wrong_labelling | 93.7 | 1 | 25 | 0 | 0 | 0 | 0 | 0 | 9 | 0 |
140 | regional_lab | QCL_0013 | lower_middle_income | peri_urban | 1 | 0 | 0 | 0 | 4 | diethylcarbamazine_50mg | anthelmintic | tablet | ambient | 0.02 | public_hospital_pharmacy | 1 | India | 1 | 2,023 | 1 | thin_layer_chromatography | pass | compliant | not_applicable | 96.3 | 1 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
141 | regional_lab | QCL_0057 | lower_middle_income | rural | 1 | 0 | 0 | 0 | 8 | amoxicillin_500mg | antibiotic | capsule | ambient | 0.02 | informal_market | 1 | India | 0 | 2,024 | 1 | HPLC | fail | falsified | expired_repackaged | 83.6 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 35 | 0 |
142 | regional_lab | QCL_0009 | low_income | rural | 1 | 0 | 0 | 0 | 5 | ciprofloxacin_500mg | antibiotic | tablet | ambient | 0.04 | wholesale_distributor | 0 | India | 0 | 2,023 | 4 | UV_spectrophotometry | pass | compliant | not_applicable | 100.7 | 1 | 25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
143 | regional_lab | QCL_0040 | low_income | urban | 1 | 0 | 0 | 0 | 5 | cotrimoxazole_480mg | antibiotic | tablet | ambient | 0.01 | public_health_centre | 1 | Europe | 0 | 2,022 | 2 | UV_spectrophotometry | pass | compliant | not_applicable | 103.4 | 1 | 39 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
144 | regional_lab | QCL_0037 | low_income | rural | 1 | 0 | 0 | 0 | 4 | doxycycline_100mg | antibiotic | capsule | ambient | 0.03 | private_pharmacy | 1 | China | 0 | 2,023 | 3 | GPHF_Minilab | fail | substandard | dissolution_failure | 94.2 | 0 | 19 | 1 | 1 | 1 | 1 | 0 | 85 | 1 |
145 | regional_lab | QCL_0010 | low_income | peri_urban | 1 | 0 | 0 | 0 | 3 | metronidazole_400mg | antibiotic | tablet | ambient | 0.02 | central_medical_store | 1 | India | 1 | 2,024 | 1 | UV_spectrophotometry | pass | compliant | not_applicable | 106.5 | 1 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
146 | regional_lab | QCL_0069 | low_income | peri_urban | 1 | 0 | 0 | 0 | 6 | artemether_lumefantrine | antimalarial | tablet | ambient | 0.04 | central_medical_store | 1 | local_SSA | 0 | 2,021 | 3 | UV_spectrophotometry | pass | compliant | not_applicable | 101.9 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
147 | regional_lab | QCL_0021 | low_income | rural | 1 | 0 | 0 | 0 | 2 | artesunate_injection | antimalarial | injection | ambient | 0.8 | informal_market | 1 | China | 0 | 2,023 | 4 | UV_spectrophotometry | fail | substandard | disintegration_failure | 96.1 | 1 | 36 | 0 | 0 | 0 | 0 | 0 | 8 | 0 |
148 | regional_lab | QCL_0057 | low_income | urban | 1 | 0 | 0 | 0 | 5 | SP_sulfadoxine_pyrimethamine | antimalarial | tablet | ambient | 0.03 | private_pharmacy | 0 | unknown | 0 | 2,024 | 1 | HPLC | pass | compliant | not_applicable | 99.4 | 1 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
149 | regional_lab | QCL_0016 | low_income | urban | 1 | 0 | 0 | 0 | 6 | chloroquine_250mg | antimalarial | tablet | ambient | 0.01 | private_clinic | 0 | India | 0 | 2,023 | 2 | HPLC | pass | compliant | not_applicable | 97.8 | 1 | 34 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
150 | regional_lab | QCL_0074 | lower_middle_income | rural | 1 | 0 | 0 | 0 | 6 | paracetamol_500mg | analgesic | tablet | ambient | 0.005 | public_hospital_pharmacy | 1 | India | 0 | 2,021 | 3 | UV_spectrophotometry | pass | compliant | not_applicable | 97 | 1 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
151 | regional_lab | QCL_0069 | lower_middle_income | rural | 1 | 0 | 0 | 0 | 5 | ibuprofen_400mg | analgesic | tablet | ambient | 0.01 | online_purchase | 1 | Europe | 0 | 2,021 | 3 | HPLC | pass | compliant | not_applicable | 98.1 | 1 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
152 | regional_lab | QCL_0036 | low_income | rural | 1 | 0 | 0 | 0 | 3 | metformin_500mg | antidiabetic | tablet | ambient | 0.01 | private_pharmacy | 0 | China | 0 | 2,023 | 3 | HPLC | fail | substandard | impurity_above_limit | 81.8 | 1 | 27 | 0 | 1 | 1 | 1 | 0 | 75 | 1 |
153 | regional_lab | QCL_0024 | lower_middle_income | peri_urban | 1 | 0 | 0 | 0 | 10 | amlodipine_5mg | antihypertensive | tablet | ambient | 0.01 | informal_market | 0 | local_SSA | 0 | 2,023 | 1 | UV_spectrophotometry | fail | falsified | no_API_detected | 0 | 0 | 12 | 1 | 1 | 0 | 1 | 0 | 21 | 0 |
154 | regional_lab | QCL_0012 | low_income | urban | 1 | 0 | 0 | 0 | 9 | omeprazole_20mg | GI | capsule | ambient | 0.03 | public_hospital_pharmacy | 1 | Europe | 0 | 2,022 | 3 | HPLC | pass | compliant | not_applicable | 102.2 | 1 | 23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
155 | regional_lab | QCL_0014 | upper_middle_income | rural | 1 | 0 | 0 | 0 | 2 | ORS_sachet | essential | powder | ambient | 0.05 | private_pharmacy | 1 | India | 0 | 2,021 | 4 | GPHF_Minilab | pass | compliant | not_applicable | 98.7 | 1 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
156 | regional_lab | QCL_0057 | low_income | rural | 1 | 0 | 0 | 0 | 6 | oxytocin_10IU | maternal | injection | cold_chain | 0.15 | informal_market | 0 | India | 0 | 2,021 | 3 | HPLC | fail | substandard | insufficient_API | 32.5 | 0 | 16 | 1 | 0 | 0 | 0 | 0 | 47 | 0 |
157 | regional_lab | QCL_0019 | low_income | urban | 1 | 0 | 0 | 0 | 6 | insulin_regular | antidiabetic | injection | cold_chain | 5 | public_hospital_pharmacy | 0 | India | 0 | 2,024 | 4 | UV_spectrophotometry | pass | compliant | not_applicable | 101.3 | 1 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
158 | regional_lab | QCL_0027 | lower_middle_income | peri_urban | 1 | 0 | 0 | 0 | 3 | TLD_dolutegravir | ARV | tablet | ambient | 0.12 | public_hospital_pharmacy | 0 | India | 0 | 2,024 | 1 | GPHF_Minilab | fail | substandard | disintegration_failure | 86.7 | 1 | 3 | 1 | 1 | 0 | 0 | 0 | 318 | 0 |
159 | regional_lab | QCL_0045 | lower_middle_income | urban | 1 | 0 | 0 | 0 | 2 | nevirapine_suspension | ARV | liquid | ambient | 0.08 | private_clinic | 0 | India | 0 | 2,023 | 4 | HPLC | fail | falsified | counterfeit_packaging | 98.2 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 41 | 0 |
160 | regional_lab | QCL_0021 | low_income | urban | 1 | 0 | 0 | 0 | 7 | diethylcarbamazine_50mg | anthelmintic | tablet | ambient | 0.02 | public_hospital_pharmacy | 1 | India | 0 | 2,024 | 3 | thin_layer_chromatography | pass | compliant | not_applicable | 98.4 | 1 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
161 | regional_lab | QCL_0049 | low_income | peri_urban | 1 | 0 | 0 | 0 | 7 | amoxicillin_500mg | antibiotic | capsule | ambient | 0.02 | informal_market | 0 | China | 0 | 2,021 | 1 | UV_spectrophotometry | fail | falsified | no_API_detected | 0 | 0 | 29 | 1 | 0 | 0 | 0 | 0 | 21 | 0 |
162 | regional_lab | QCL_0057 | low_income | urban | 1 | 0 | 0 | 0 | 8 | ciprofloxacin_500mg | antibiotic | tablet | ambient | 0.04 | public_hospital_pharmacy | 1 | India | 0 | 2,023 | 4 | HPLC | fail | substandard | insufficient_API | 51 | 0 | 30 | 1 | 1 | 0 | 0 | 0 | 9 | 0 |
163 | regional_lab | QCL_0025 | lower_middle_income | rural | 1 | 0 | 0 | 0 | 5 | cotrimoxazole_480mg | antibiotic | tablet | ambient | 0.01 | informal_market | 1 | India | 1 | 2,021 | 3 | UV_spectrophotometry | pass | compliant | not_applicable | 101.1 | 1 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
164 | regional_lab | QCL_0037 | lower_middle_income | peri_urban | 1 | 0 | 0 | 0 | 6 | doxycycline_100mg | antibiotic | capsule | ambient | 0.03 | central_medical_store | 1 | India | 0 | 2,024 | 2 | HPLC | fail | falsified | counterfeit_packaging | 83.4 | 1 | 54 | 0 | 0 | 0 | 0 | 0 | 295 | 1 |
165 | regional_lab | QCL_0016 | low_income | urban | 1 | 0 | 0 | 0 | 1 | metronidazole_400mg | antibiotic | tablet | ambient | 0.02 | private_pharmacy | 0 | USA | 0 | 2,023 | 3 | thin_layer_chromatography | fail | substandard | dissolution_failure | 80.8 | 0 | 32 | 1 | 1 | 1 | 1 | 0 | 23 | 0 |
166 | regional_lab | QCL_0045 | low_income | peri_urban | 1 | 0 | 0 | 0 | 3 | artemether_lumefantrine | antimalarial | tablet | ambient | 0.04 | private_clinic | 0 | Europe | 0 | 2,023 | 4 | thin_layer_chromatography | fail | falsified | no_API_detected | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 24 | 0 |
167 | regional_lab | QCL_0045 | lower_middle_income | peri_urban | 1 | 0 | 0 | 0 | 6 | artesunate_injection | antimalarial | injection | ambient | 0.8 | public_hospital_pharmacy | 1 | unknown | 0 | 2,020 | 3 | GPHF_Minilab | pass | compliant | not_applicable | 98.8 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
168 | regional_lab | QCL_0053 | lower_middle_income | rural | 1 | 0 | 0 | 0 | 8 | SP_sulfadoxine_pyrimethamine | antimalarial | tablet | ambient | 0.03 | public_health_centre | 1 | local_SSA | 0 | 2,024 | 4 | HPLC | pass | compliant | not_applicable | 102.4 | 1 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
169 | regional_lab | QCL_0007 | lower_middle_income | urban | 1 | 0 | 0 | 0 | 8 | chloroquine_250mg | antimalarial | tablet | ambient | 0.01 | informal_market | 1 | China | 0 | 2,020 | 3 | HPLC | fail | substandard | impurity_above_limit | 98.1 | 1 | 7 | 0 | 0 | 0 | 0 | 0 | 28 | 0 |
170 | regional_lab | QCL_0028 | lower_middle_income | urban | 1 | 0 | 0 | 0 | 7 | paracetamol_500mg | analgesic | tablet | ambient | 0.005 | private_clinic | 0 | India | 0 | 2,020 | 1 | UV_spectrophotometry | fail | falsified | no_API_detected | 0 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 18 | 0 |
171 | regional_lab | QCL_0075 | lower_middle_income | peri_urban | 1 | 0 | 0 | 0 | 1 | ibuprofen_400mg | analgesic | tablet | ambient | 0.01 | public_hospital_pharmacy | 0 | Europe | 0 | 2,024 | 4 | GPHF_Minilab | fail | substandard | dissolution_failure | 86.6 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 115 | 0 |
172 | regional_lab | QCL_0031 | low_income | rural | 1 | 0 | 0 | 0 | 9 | metformin_500mg | antidiabetic | tablet | ambient | 0.01 | private_pharmacy | 0 | unknown | 0 | 2,023 | 2 | thin_layer_chromatography | pass | compliant | not_applicable | 97.9 | 1 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
173 | regional_lab | QCL_0049 | lower_middle_income | urban | 1 | 0 | 0 | 0 | 8 | amlodipine_5mg | antihypertensive | tablet | ambient | 0.01 | private_clinic | 1 | local_SSA | 0 | 2,024 | 2 | UV_spectrophotometry | pass | compliant | not_applicable | 100.1 | 1 | 17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
174 | regional_lab | QCL_0042 | lower_middle_income | rural | 1 | 0 | 0 | 0 | 9 | omeprazole_20mg | GI | capsule | ambient | 0.03 | private_pharmacy | 1 | China | 0 | 2,021 | 4 | HPLC | pass | compliant | not_applicable | 101.9 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
175 | regional_lab | QCL_0003 | low_income | rural | 1 | 0 | 0 | 0 | 4 | ORS_sachet | essential | powder | ambient | 0.05 | wholesale_distributor | 1 | unknown | 0 | 2,021 | 2 | HPLC | pass | compliant | not_applicable | 100.5 | 1 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
176 | regional_lab | QCL_0020 | upper_middle_income | peri_urban | 1 | 0 | 0 | 0 | 7 | oxytocin_10IU | maternal | injection | cold_chain | 0.15 | street_vendor | 0 | unknown | 0 | 2,021 | 4 | GPHF_Minilab | pass | compliant | not_applicable | 101.6 | 1 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
177 | regional_lab | QCL_0018 | lower_middle_income | urban | 1 | 0 | 0 | 0 | 5 | insulin_regular | antidiabetic | injection | cold_chain | 5 | online_purchase | 1 | Europe | 0 | 2,022 | 2 | thin_layer_chromatography | pass | compliant | not_applicable | 95.4 | 1 | 17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
178 | regional_lab | QCL_0059 | low_income | rural | 1 | 0 | 0 | 0 | 3 | TLD_dolutegravir | ARV | tablet | ambient | 0.12 | central_medical_store | 0 | unknown | 0 | 2,024 | 4 | UV_spectrophotometry | pass | compliant | not_applicable | 98.8 | 1 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
179 | regional_lab | QCL_0035 | low_income | urban | 1 | 0 | 0 | 0 | 4 | nevirapine_suspension | ARV | liquid | ambient | 0.08 | informal_market | 0 | local_SSA | 0 | 2,023 | 4 | HPLC | fail | substandard | moisture_content | 99.5 | 1 | 3 | 1 | 0 | 0 | 0 | 0 | 36 | 0 |
180 | regional_lab | QCL_0062 | lower_middle_income | peri_urban | 1 | 0 | 0 | 0 | 4 | diethylcarbamazine_50mg | anthelmintic | tablet | ambient | 0.02 | informal_market | 1 | USA | 1 | 2,024 | 4 | UV_spectrophotometry | pass | compliant | not_applicable | 100.2 | 1 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
181 | regional_lab | QCL_0035 | lower_middle_income | peri_urban | 1 | 0 | 0 | 0 | 4 | amoxicillin_500mg | antibiotic | capsule | ambient | 0.02 | private_pharmacy | 1 | India | 1 | 2,021 | 1 | UV_spectrophotometry | pass | compliant | not_applicable | 97.2 | 1 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
182 | regional_lab | QCL_0038 | lower_middle_income | urban | 1 | 0 | 0 | 0 | 3 | ciprofloxacin_500mg | antibiotic | tablet | ambient | 0.04 | private_clinic | 0 | local_SSA | 0 | 2,022 | 4 | HPLC | pass | compliant | not_applicable | 98.9 | 1 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
183 | regional_lab | QCL_0024 | low_income | rural | 1 | 0 | 0 | 0 | 3 | cotrimoxazole_480mg | antibiotic | tablet | ambient | 0.01 | public_hospital_pharmacy | 1 | unknown | 0 | 2,023 | 2 | HPLC | fail | substandard | insufficient_API | 55.3 | 0 | 35 | 1 | 0 | 0 | 0 | 0 | 11 | 1 |
184 | regional_lab | QCL_0004 | upper_middle_income | urban | 1 | 0 | 0 | 0 | 3 | doxycycline_100mg | antibiotic | capsule | ambient | 0.03 | private_pharmacy | 0 | China | 0 | 2,024 | 2 | GPHF_Minilab | pass | compliant | not_applicable | 105.1 | 1 | 34 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
185 | regional_lab | QCL_0071 | lower_middle_income | rural | 1 | 0 | 0 | 0 | 10 | metronidazole_400mg | antibiotic | tablet | ambient | 0.02 | online_purchase | 0 | unknown | 0 | 2,023 | 4 | UV_spectrophotometry | fail | substandard | insufficient_API | 67.1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 3 | 0 |
186 | regional_lab | QCL_0017 | upper_middle_income | peri_urban | 1 | 0 | 0 | 0 | 3 | artemether_lumefantrine | antimalarial | tablet | ambient | 0.04 | online_purchase | 0 | India | 0 | 2,022 | 2 | HPLC | pass | compliant | not_applicable | 100.7 | 1 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
187 | regional_lab | QCL_0032 | low_income | urban | 1 | 0 | 0 | 0 | 12 | artesunate_injection | antimalarial | injection | ambient | 0.8 | online_purchase | 0 | India | 0 | 2,024 | 1 | GPHF_Minilab | fail | substandard | microbial_contamination | 82.2 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 2 | 0 |
188 | regional_lab | QCL_0001 | low_income | peri_urban | 1 | 0 | 0 | 0 | 5 | SP_sulfadoxine_pyrimethamine | antimalarial | tablet | ambient | 0.03 | public_health_centre | 0 | India | 0 | 2,020 | 1 | HPLC | pass | compliant | not_applicable | 99.1 | 1 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
189 | regional_lab | QCL_0075 | low_income | peri_urban | 1 | 0 | 0 | 0 | 3 | chloroquine_250mg | antimalarial | tablet | ambient | 0.01 | public_health_centre | 0 | unknown | 0 | 2,024 | 3 | UV_spectrophotometry | pass | compliant | not_applicable | 97.5 | 1 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
190 | regional_lab | QCL_0023 | low_income | rural | 1 | 0 | 0 | 0 | 6 | paracetamol_500mg | analgesic | tablet | ambient | 0.005 | street_vendor | 1 | Europe | 0 | 2,023 | 2 | UV_spectrophotometry | pass | compliant | not_applicable | 98.4 | 1 | 21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
191 | regional_lab | QCL_0041 | low_income | peri_urban | 1 | 0 | 0 | 0 | 4 | ibuprofen_400mg | analgesic | tablet | ambient | 0.01 | wholesale_distributor | 1 | local_SSA | 0 | 2,020 | 1 | UV_spectrophotometry | fail | substandard | excess_API | 157.7 | 1 | 13 | 1 | 0 | 0 | 0 | 0 | 776 | 0 |
192 | regional_lab | QCL_0012 | low_income | urban | 1 | 0 | 0 | 0 | 3 | metformin_500mg | antidiabetic | tablet | ambient | 0.01 | central_medical_store | 1 | China | 0 | 2,024 | 2 | GPHF_Minilab | pass | compliant | not_applicable | 94.6 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
193 | regional_lab | QCL_0046 | lower_middle_income | rural | 1 | 0 | 0 | 0 | 4 | amlodipine_5mg | antihypertensive | tablet | ambient | 0.01 | central_medical_store | 1 | India | 0 | 2,021 | 4 | HPLC | pass | compliant | not_applicable | 98.1 | 1 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
194 | regional_lab | QCL_0009 | lower_middle_income | rural | 1 | 0 | 0 | 0 | 8 | omeprazole_20mg | GI | capsule | ambient | 0.03 | private_clinic | 0 | local_SSA | 0 | 2,022 | 2 | HPLC | pass | compliant | not_applicable | 105.4 | 1 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
195 | regional_lab | QCL_0025 | lower_middle_income | rural | 1 | 0 | 0 | 0 | 5 | ORS_sachet | essential | powder | ambient | 0.05 | private_pharmacy | 1 | India | 0 | 2,023 | 3 | HPLC | fail | falsified | no_API_detected | 0 | 0 | 49 | 1 | 0 | 0 | 0 | 0 | 40 | 0 |
196 | regional_lab | QCL_0068 | low_income | rural | 1 | 0 | 0 | 0 | 6 | oxytocin_10IU | maternal | injection | cold_chain | 0.15 | private_pharmacy | 1 | India | 0 | 2,022 | 2 | HPLC | fail | substandard | insufficient_API | 48.1 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 7 | 0 |
197 | regional_lab | QCL_0072 | low_income | peri_urban | 1 | 0 | 0 | 0 | 4 | insulin_regular | antidiabetic | injection | cold_chain | 5 | private_pharmacy | 1 | India | 0 | 2,024 | 1 | GPHF_Minilab | pass | compliant | not_applicable | 100 | 1 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
198 | regional_lab | QCL_0001 | low_income | urban | 1 | 0 | 0 | 0 | 5 | TLD_dolutegravir | ARV | tablet | ambient | 0.12 | public_health_centre | 0 | India | 0 | 2,023 | 1 | HPLC | fail | substandard | insufficient_API | 31.2 | 0 | 46 | 1 | 0 | 0 | 0 | 0 | 34 | 0 |
199 | regional_lab | QCL_0065 | low_income | rural | 1 | 0 | 0 | 0 | 6 | nevirapine_suspension | ARV | liquid | ambient | 0.08 | informal_market | 0 | unknown | 0 | 2,023 | 2 | HPLC | fail | substandard | insufficient_API | 45.5 | 0 | 16 | 0 | 0 | 0 | 0 | 0 | 56 | 0 |
200 | regional_lab | QCL_0041 | low_income | rural | 1 | 0 | 0 | 0 | 4 | diethylcarbamazine_50mg | anthelmintic | tablet | ambient | 0.02 | street_vendor | 0 | local_SSA | 0 | 2,023 | 4 | UV_spectrophotometry | pass | compliant | not_applicable | 103 | 1 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.